⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NAGE News
Niagen Bioscience, Inc. Common Stock
Andrew Shao, Ph.D., Senior Vice President of Global Regulatory and Scientific Affairs at Niagen Bioscience, Honored with the 2026 Annette Dickinson Trailblazer Award by Radicle Science and Council for Responsible Nutrition (CRN)
businesswire.com
NAGE
Niagen Bioscience Puts 25 Years of NAD+ Science Behind "Don't Get Old. Age Better. ®” a New Campaign for its Niagen® Brand Featuring Legendary Surfer Kelly Slater
businesswire.com
NAGE
Niagen Bioscience Launches Tru Niagen on Walmart.com, Expanding Access and Diversifying Its E-commerce Marketplace Presence
businesswire.com
NAGE
Form 8-K
sec.gov
NAGE
Niagen Bioscience, Inc. Reports Second Quarter 2026 Financial Results
businesswire.com
NAGE
Niagen Bioscience Selects Global Drug Development Pioneer Evotec to Advance Preclinical Development for NB4168
businesswire.com
NAGE
Niagen Bioscience to Present at Canaccord Genuity’s 46th Annual Growth Conference
businesswire.com
NAGE
Niagen Bioscience Appoints Abhijit Kale, Ph.D., as Senior Director of Global External Research
businesswire.com
NAGE
Niagen Bioscience Receives Exclusive U.S. FDA Rare Pediatric Disease (RPD) Designation and European Medicines Agency Orphan Medicinal Product Designation (OMPD) for NB4168 for the Treatment of Ataxia Telangiectasia (A-T)
businesswire.com
NAGE
Niagen Bioscience CEO Rob Fried to Participate in Virtual Fireside Chat to Discuss Pharmaceutical Strategy on July 15, 2026
businesswire.com
NAGE